Sequence of DPRE2_MYCTU

decaprenylphospho-beta-D-erythro-pentofuranosid-2-ulose 2-reductase

P9WGS9

254

27469

664740

Cole S.T.,Brosch R.,Parkhill J.,Garnier T.,Churcher C.M.,Harris D.E.,Gordon S.V.,Eiglmeier K.,Gas S.,Barry C.E. III,Tekaia F.,Badcock K.,Basham D.,Brown D.,Chillingworth T.,Connor R.,Davies R.M.,Devlin K.,Feltwell T.,Gentles S.,Hamlin N.,Holroyd S.,Hornsby T.,Jagels K.,Krogh A.,McLean J.,Moule S.,Murphy L.D.,Oliver S.,Osborne J.,Quail M.A.,Rajandream M.A.,Rogers J.,Rutter S.,Seeger K.,Skelton S.,Squares S.,Squares R.,Sulston J.E.,Taylor K.,Whitehead S.,Barrell B.G.

Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence.

Nature

393

537-544

1998

664741

Sassetti C.M.,Boyd D.H.,Rubin E.J.

Genes required for mycobacterial growth defined by high density mutagenesis.

Mol. Microbiol.

48

77-84

2003

664742

Mikusova K.,Huang H.,Yagi T.,Holsters M.,Vereecke D.,D'Haeze W.,Scherman M.S.,Brennan P.J.,McNeil M.R.,Crick D.C.

Decaprenylphosphoryl arabinofuranose, the donor of the D-arabinofuranosyl residues of mycobacterial arabinan, is formed via a two-step epimerization of decaprenylphosphoryl ribose.

J. Bacteriol.

187

8020-8025

2005

664743

Raman K.,Yeturu K.,Chandra N.

targetTB: a target identification pipeline for Mycobacterium tuberculosis through an interactome, reactome and genome-scale structural analysis.

BMC Syst. Biol.

2

109-109

2008

664744

Makarov V.,Manina G.,Mikusova K.,Mollmann U.,Ryabova O.,Saint-Joanis B.,Dhar N.,Pasca M.R.,Buroni S.,Lucarelli A.P.,Milano A.,De Rossi E.,Belanova M.,Bobovska A.,Dianiskova P.,Kordulakova J.,Sala C.,Fullam E.,Schneider P.,McKinney J.D.,Brodin P.,Christophe T.,Waddell S.,Butcher P.,Albrethsen J.,Rosenkrands I.,Brosch R.,Nandi V.,Bharath S.,Gaonkar S.,Shandil R.K.,Balasubramanian V.,Balganesh T.,Tyagi S.,Grosset J.,Riccardi G.,Cole S.T.

Benzothiazinones kill Mycobacterium tuberculosis by blocking arabinan synthesis.

Science

324

801-804

2009

664745

Kelkar D.S.,Kumar D.,Kumar P.,Balakrishnan L.,Muthusamy B.,Yadav A.K.,Shrivastava P.,Marimuthu A.,Anand S.,Sundaram H.,Kingsbury R.,Harsha H.C.,Nair B.,Prasad T.S.,Chauhan D.S.,Katoch K.,Katoch V.M.,Kumar P.,Chaerkady R.,Ramachandran S.,Dash D.,Pandey A.

Proteogenomic analysis of Mycobacterium tuberculosis by high resolution mass spectrometry.

Mol. Cell. Proteomics

10

0-0

2011

664746

Batt S.M.,Jabeen T.,Bhowruth V.,Quill L.,Lund P.A.,Eggeling L.,Alderwick L.J.,Futterer K.,Besra G.S.

Structural basis of inhibition of Mycobacterium tuberculosis DprE1 by benzothiazinone inhibitors.

Proc. Natl. Acad. Sci. U.S.A.

109

11354-11359

2012

664747

Kolly G.S.,Boldrin F.,Sala C.,Dhar N.,Hartkoorn R.C.,Ventura M.,Serafini A.,McKinney J.D.,Manganelli R.,Cole S.T.

Assessing the essentiality of the decaprenyl-phospho-D-arabinofuranose pathway in Mycobacterium tuberculosis using conditional mutants.

Mol. Microbiol.

92

194-211

2014

664748

Brecik M.,Centarova I.,Mukherjee R.,Kolly G.S.,Huszar S.,Bobovska A.,Kilacskova E.,Mokosova V.,Svetlikova Z.,Sarkan M.,Neres J.,Kordulakova J.,Cole S.T.,Mikusova K.

DprE1 is a vulnerable tuberculosis drug target due to its cell wall localization.

ACS Chem. Biol.

10

1631-1636

2015

664749

Bhutani I.,Loharch S.,Gupta P.,Madathil R.,Parkesh R.

Structure, dynamics, and interaction of Mycobacterium tuberculosis (Mtb) DprE1 and DprE2 examined by molecular modeling, simulation, and electrostatic studies.

PLoS ONE

10

0-0

2015